-+ 0.00%
-+ 0.00%
-+ 0.00%
Credo Stock Has a Powerful Growth Story, but Is It Already Priced In?
Share
Listen to the news

The 24/7 Wall St. price target for Credo (NASDAQ:CRDO) is $206.69. The target implies 36.97% upside from the $150.90 close on November 3, 2026, and our model carries high conviction.

An infographic titled '24/7 Wall St. CRDO NASDAQ 12-Month Price Prediction'. The main header shows '$150.90 -> $206.69 +37% BUY' with a 'High Confidence: 90%' label. Below, a section 'HOW WE GOT THERE' uses a horizontal stacked bar chart to show a weighted base of $180.20 derived from Forward P/E-Based Price ($129.61, 50%), Analyst Consensus Target ($284.05, 30%), and Trailing P/E-Based Price ($150.90, 20%). The next section, 'OUR ADJUSTMENTS', is a waterfall-style chart starting with a base of $180.20, adding Sector Momentum, Analyst Consensus, and Earnings Growth (green bars with plus signs), and subtracting Volatility, Social Sentiment, and Market-Cap Dampening (red bars with minus signs), arriving at a final target of $206.69 with an adjusted 1.147x factor. The 'BULL CASE' section lists three bullet points on growth and a target of $332.89 (+121%) with a green border. The 'BEAR CASE' section lists three bullet points on risks and a target of $168.03 (+11%) with a red border. The 'THE BOTTOM LINE' states 'BUY | Target: $206.69 (+37%)' and 'Strong growth story at 21x forward earnings'. Logos for 24/7 Wall St. are present at the top left and bottom center.24/7 Wall St. Metric Value Current Price $150.90 Price Target from 24/7 Wall St. $206.69 Upside/Downside 36.97% Recommendation BUY Confidence Level 90%

Credo shares are down sharply even as the business continues accelerating. Management expects fiscal 2027 revenue growth above 85%. The recent selloff has already taken a lot of the excitement out of the stock price. Shares were showed at $145.80 ahead of the November 4 open.

A 33% One-Month Slide Resets Expectations

Credo fell 12.92% over the past week and 33.32% over the past month. That leaves it up just 1.33% year to date. At $150.90, the stock trades 51% below its 52-week peak of $308.67 and 74% above its trough of $86.48. The drop came after a strong quarter.

Q1 fiscal 2027 revenue of $479.0M rose 114.7% and beat the $470.4M consensus. Non-GAAP EPS of $1.20 exceeded the $1.17 estimate, making it Credo’s 8th consecutive beat. Q2 guidance calls for revenue of $525M-$535M.

Optics Could Drive Credo Toward $332

The bull case reaches $332.89, a 120.61% gain. Management expects optical revenue above $600 million in fiscal 2027. ZeroFlap optics, silicon photonics PICs and optical DSPs should each contribute more than $100 million.

OmniConnect, which begins generating revenue in fiscal 2028, could add “thousands of dollars of Credo content per GPU.” Wall Street is overwhelmingly bullish. Analysts list 5 Strong Buys, 14 Buys, one Hold and no Sells. Their consensus target of $284.05 implies 88% upside.

Customer Concentration Is the Risk to Watch

Credo’s largest customer accounted for 33% of revenue last quarter, and the next largest accounted for 28%. GAAP gross margin slipped to 64.5% from 68.2%. Most of that decline reflects amortization from the Dust Photonics acquisition, which raised goodwill to $986.45M. On a non-GAAP basis, gross margin held at 68%.

Stock-based compensation reached $87.98M, and inventory rose to $313.1 million. Management says the inventory build is intentional supply preparation. Our bear case of $168.03 still sits above today’s price. However, last month’s slide shows that a stock with this much volatility can fall further than any model expects.

How Credo Compares to Broadcom, Marvell and Astera Labs

The scale benchmark for AI networking is Broadcom (NASDAQ:AVGO). Its AI semiconductor revenue reached $16.70 billion, up 221%. Credo has narrower exposure but grows faster in total (we covered seven of these AI infrastructure suppliers, from power to networking, in a free report you can grab here).

Marvell Technology (NASDAQ:MRVL) competes directly in optical DSPs. Its revenue grew 36.55% with a non-GAAP gross margin of 58.9%, below Credo’s 68%.

Astera Labs (NASDAQ:ALAB) is the closest pure-play comparison. The multiple sits at 185x earnings, while Credo trades at 21x forward earnings. Against this group, our target looks conservative.

Company Latest Quarter Revenue Growth Latest Non-GAAP EPS Credo 114.7% $1.20 Broadcom 85.5% $3.32 Marvell 36.55% $0.94 Astera Labs 153.67% $1.32 Triple-Digit Growth at 21x Forward Earnings Tips the Scale

Our 24/7 Wall St. price target remains $206.69, with a buy rating and 90% confidence. The deciding factor for me is the valuation: a business growing triple digits now trades at 21x forward earnings.

The bull case strengthens if the optical ramps meet the $600 million target. The thesis weakens if the largest customers start cutting orders. At today’s price, I think the growth story has been marked down too far.

Our model projects the following path over a longer horizon, given current growth trends and market conditions hold.

Year Price Target from 24/7 Wall St. 2026 $206.69 2027 $216.19 2028 $266.82 2029 $311.81 2030 $348.03

The projections rest on Credo continuing to carry out its optical and copper strategy. A shift in hyperscaler AI spending could drive results well above or below this path.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending